PFBT
AKRO

Parkside Financial Bank & Trust’s Akero Therapeutics AKRO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$951 – 2686
2025
Q3 		$951 Sell
20
-30
-60% -$1.45K ﹤0.01% 2302
2025
Q2 		$2.67K Buy
50
+20
+67% +$909 ﹤0.01% 1898
2025
Q1 		$1.22K Buy
+30
New +$1.27K ﹤0.01% 2039

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parkside Financial Bank & Trust's AKRO Position: Q4 2025 in Review

Parkside Financial Bank & Trust sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 20 shares — an estimated $951 sold.

Parkside Financial Bank & Trust first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $2.67K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Parkside Financial Bank & Trust reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 20 Akero Therapeutics shares in Q4 2025, an estimated $951.
  • Parkside Financial Bank & Trust first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Akero Therapeutics position peaked at $2.67K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2025, filed 13 Feb 2026.